Table of Contents

Articles

• You have access

  Discovery and Mapping of an Intracellular Antagonist Binding Site at the Chemokine Receptor CCR2

  Annelien J.M. Zweemer, Julia Bunnik, Margo Veenhuizen, Fabiana Miraglia, Eelke B. Lenselink, Maris Vilums, Henk de Vries, Arthur Gibert, Stefanie Thiele, Mette M. Rosenkilde, Adriaan P. IJzerman and Laura H. Heitman

  Molecular Pharmacology October 2014, 86 (4) 358-368; DOI: https://doi.org/10.1124/mol.114.093328
• You have access

  G-Protein βγ Subunit Dimers Modulate Kidney Repair after Ischemia-Reperfusion Injury in Rats

  Sarah M. White, Lauren M. North, Emily Haines, Megan Goldberg, Lydia M. Sullivan, Jeffrey D. Pressly, David S. Weber, Frank Park and Kevin R. Regner

  Molecular Pharmacology October 2014, 86 (4) 369-377; DOI: https://doi.org/10.1124/mol.114.092346
• You have access

  Fluoxetine Blocks Na_v1.5 Channels via a Mechanism Similar to That of Class 1 Antiarrhythmics

  Hugo Poulin, Iva Bruhova, Quadiri Timour, Olivier Theriault, Jean-Martin Beaulieu, Dominique Frassati and Mohamed Chahine

  Molecular Pharmacology October 2014, 86 (4) 378-389; DOI: https://doi.org/10.1124/mol.114.093104
• You have access

  A Role for Picomolar Concentrations of Pregnenolone Sulfate in Synaptic Activity-Dependent Ca²⁺ Signaling and CREB Activation

  Conor C. Smith, Stella C. Martin, Kavitha Sugunan, Shelley J. Russek, Terrell T. Gibbs and David H. Farb

  Molecular Pharmacology October 2014, 86 (4) 390-398; DOI: https://doi.org/10.1124/mol.114.094128
• You have access

  The Phosphatidylinositol(4,5)Bisphosphate–Binding Sequence of Transient Receptor Potential Channel Canonical 4α Is Critical for Its Contribution to Cardiomyocyte Hypertrophy

  Nicola Cooley, David R. Grubb, Jieting Luo and Elizabeth A. Woodcock

  Molecular Pharmacology October 2014, 86 (4) 399-405; DOI: https://doi.org/10.1124/mol.114.093690
• You have access

  Identification of Protein Kinase C Activation as a Novel Mechanism for RGS2 Protein Upregulation through Phenotypic Screening of Natural Product Extracts

  Avi Raveh, Pamela J. Schultz, Lauren Aschermann, Colleen Carpenter, Giselle Tamayo-Castillo, Shugeng Cao, Jon Clardy, Richard R. Neubig, David H. Sherman and Benita Sjögren

  Molecular Pharmacology October 2014, 86 (4) 406-416; DOI: https://doi.org/10.1124/mol.114.092403
• You have access

  Functional Selectivity of Allosteric Interactions within G Protein–Coupled Receptor Oligomers: The Dopamine D₁-D₃ Receptor Heterotetramer

  Xavier Guitart, Gemma Navarro, Estefania Moreno, Hideaki Yano, Ning-Sheng Cai, Marta Sánchez-Soto, Sandeep Kumar-Barodia, Yamini T. Naidu, Josefa Mallol, Antoni Cortés, Carme Lluís, Enric I. Canela, Vicent Casadó, Peter J. McCormick and Sergi Ferré

  Molecular Pharmacology October 2014, 86 (4) 417-429; DOI: https://doi.org/10.1124/mol.114.093096
• You have access

  Adverse Effects of Doxorubicin and Its Metabolic Product on Cardiac RyR2 and SERCA2A

  Amy D. Hanna, Alex Lam, Steffi Tham, Angela F. Dulhunty and Nicole A. Beard

  Molecular Pharmacology October 2014, 86 (4) 438-449; DOI: https://doi.org/10.1124/mol.114.093849
• You have access

  Regulation of Mitochondrial Poly(ADP-Ribose) Polymerase Activation by the β-Adrenoceptor/cAMP/Protein Kinase A Axis during Oxidative Stress

  Attila Brunyanszki, Gabor Olah, Ciro Coletta, Bartosz Szczesny and Csaba Szabo

  Molecular Pharmacology October 2014, 86 (4) 450-462; DOI: https://doi.org/10.1124/mol.114.094318